◀ Back to JUN
GSK3B — JUN
Pathways - manually collected, often from reviews:
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
Text-mined interactions from Literome
Ma et al., Cancer Res 2007
(Carcinoma, Basal Cell...) :
Inhibition of
GSK3beta activation significantly
stimulated activator protein-1 (AP-1) activity
Larabee et al., Infect Immun 2008
:
GSK-3beta inhibitors
prevented declines in cellular levels of cyclin D1 and
c-Jun following treatment of macrophages with ET